NIKKEI 225
28,743.25-121.07(-0.42%)HANG SENG
28,540.83-557.46(-1.92%)CRUDE OIL
64.92-1.17(-1.77%)
Tilray, Inc. (TLRY)
| Previous close | 21.63 |
| Open | 21.73 |
| Bid | 22.82 x 1000 |
| Ask | 22.86 x 800 |
| Day's range | 20.80 - 23.42 |
| 52-week range | 2.43 - 67.00 |
| Volume | 11,615,958 |
| Avg. volume | 40,180,436 |
| Market cap | 3.924B |
| Beta (5Y monthly) | 2.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.15 |
| Earnings date | 17 Feb 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 19.32 |
- Motley Fool
Is Tilray Stock a Buy?
Canadian weed giant Tilray (NASDAQ: TLRY) was on a tear for much of 2020. Investors have a lot to be thrilled about with Tilray, the most promising of which is its substantial international presence, which will become a game-changer as more countries legalize the recreational and medical use of cannabis. Let's investigate how Tilray can capitalize on marijuana's entry to the mainstream.
- Motley Fool
Why Aphria Rose 46.2% in February
The Canadian pot stock rose amid a Reddit-fueled rally and positive earnings results from Tilray, which will merge with Aphria next quarter.
- Motley Fool
Why Tilray Stock Rose 35% in February
Tilray (NASDAQ: TLRY) stock outperformed a rising market last month. Shares soared 35% in February compared to a 2.6% gain in the S&P 500, according to data provided by S&P Global Market Intelligence. Tilray announced positive earnings results last month, with fourth-quarter sales increasing 26% as net loss improved to $3 million from $220 million a year earlier.
